Stream SL

Hauptinformation

  • Handelsname:
  • Stream SL
  • Verwenden für:
  • Pflanzen
  • Art der Medizin:
  • Agrochemisch

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Stream SL
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Herbizid

Weitere Informationen

Status

  • Quelle:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Zulassungsnummer:
  • I-2727
  • Letzte Änderung:
  • 06-09-2017

Packungsbeilage

Produkt:

Handelsbezeichnung: Stream SL (Parallelimport)

Bewilligung beendet: Ausverkaufsfrist: 31.05.2018, Aufbrauchfrist: 31.05.2019

Produktekategorie

Ausl. Bewilligungsinhaber

Eidg.

Zulassungsnummer

Herbizid

Cheminova Agro Italia S.R.L.

I-2727

Packungsbeilagenummer Herkunftsland

Ausl.

Zulassungsnummer

6700

Italien

8429

Stoff(e)

Gehalt

Formulierungscode

Wirkstoff: Glyphosat

30.8 % 360 g/l

[als 41.5% Glyphosat-isopropylammoniumsalz (486

g/l)]

SL Wasserlösliches

Konzentrat

Anwendungen

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

B Brombeere

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 3

B Brombeere

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 3

O Kernobst

Steinobst

Einjährige

Dicotyledonen

(Unkräuter)

Aufwandmenge: 2 - 3 l/ha

1, 2, 3

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Kernobst

Steinobst

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 3

W Ertragsreben

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 3

W Ertragsreben

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 3

G Brache

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 4

G Brache

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 4

Brache

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 4

Brache

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Aufwandmenge: 4 - 10 l/ha

1, 2, 4

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Monocotyledonen

(Ungräser)

Mais

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

Anwendung: Bei der Saat.

1, 2, 5, 6

Mais

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

Anwendung: Bei der Saat.

1, 2, 5, 6

Wiesen und Weiden

Dicotyledonen

(Unkräuter)

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

Anwendung:

Flächenbehandlung; vor

Neuansaat.

1, 2, 4

Wiesen und Weiden

Dicotyledonen

(Unkräuter)

Monocotyledonen

(Ungräser)

Konzentration: 5 - 10 %

Wartefrist: 3 Woche(n)

Anwendung:

Einzelpflanzenbehandlung mit

Handspritzgeräten.

1, 2, 7

Wiesen und Weiden

Dicotyledonen

(Unkräuter)

Monocotyledonen

(Ungräser)

Konzentration: 0.5 - 1.5 %

Wartefrist: 3 Woche(n)

Anwendung:

Einzelpflanzenbehandlung mit

Rückenspritze.

1, 2, 7

Bäume und Sträucher (ausserhalb

Forst)

Rosen

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 3

Bäume und Sträucher (ausserhalb

Forst)

Rosen

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 3

Z Brache

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Aufwandmenge: 2 - 3 l/ha

1, 2, 4

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

Monocotyledonen

(Ungräser)

Gemeine Quecke

Z Brache

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 4

Forstliche Pflanzgärten

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 3

Forstliche Pflanzgärten

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 3

Auf und an National- und

Kantonsstrassen

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 8

Auf und an National- und

Kantonsstrassen

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 4 - 10 l/ha

1, 2, 8

Böschungen und Grünstreifen

entlang von Verkehrswegen

(gem. ChemRRV)

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Gemeine Quecke

Aufwandmenge: 2 - 3 l/ha

1, 2, 8

N Böschungen und Grünstreifen

entlang von Verkehrswegen

(gem. ChemRRV)

Mehrjährige

Dicotyledonen

(Unkräuter)

Mehrjährige

Monocotyledonen

Aufwandmenge: 4 - 10 l/ha

1, 2, 8

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

(Ungräser)

N Humusdeponie

Ackerkratzdistel

Stumpfblättriger Ampfer

(Blacken)

Konzentration: 5 - 10 %

Anwendung:

Einzelpflanzenbehandlung mit

Handspritzgeräten.

1, 2

Ö Grünfläche

Ackerkratzdistel

Stumpfblättriger Ampfer

(Blacken)

Konzentration: 5 - 10 %

Anwendung: Mit

Handspritzgeräten (ohne

Rückenspritze).

1, 2, 7, 9

Ö Grünfläche

Ackerkratzdistel

Stumpfblättriger Ampfer

(Blacken)

Konzentration: 0.5 - 1.5 %

Anwendung: Mit Rückenspritze.

1, 2, 7, 9,

Ö Offene Ackerfläche

Ackerkratzdistel

Gemeine Quecke

Stumpfblättriger Ampfer

(Blacken)

Konzentration: 5 - 10 %

Anwendung: Mit

Handspritzgeräten (ohne

Rückenspritze).

1, 2, 9

Ö Offene Ackerfläche

Ackerkratzdistel

Gemeine Quecke

Stumpfblättriger Ampfer

(Blacken)

Konzentration: 0.5 - 1.5 %

Anwendung: Mit Rückenspritze.

1, 2, 9, 10

Auflagen und Bemerkungen:

Keine Niederschläge während mindestens 6 Stunden nach der Behandlung.

Ansetzen der Spritzbrühe: Schutzhandschuhe tragen.

Behandlung spätestens bis Ende August. Es dürfen keine grünen Teile der Kulturpflanzen mit dem

Herbizid in Kontakt kommen.

Behandlung bis spätestens 2 Wochen vor der Saat oder Pflanzung.

Die Aufwandmenge bezieht sich auf die effektiv zu behandelnde Fläche.

Behandlung der unbearbeiteten Zwischenreihen bei der Streifenfrässaat.

Beweidung oder Schnitt (Grünfutter oder Konservierung) frühestens 3 Wochen nach der

Behandlung. Ausnahme: Für nicht laktierende Tiere beträgt die Wartefrist 2 Wochen.

Gemäss Chemikalien-Risikoreduktions-Verordnung (ChemRRV): Nur Einzelpflanzenbehandlung

anderweitig nicht bekämpfbarer Problempflanzen.

Einzelpflanzenbehandlung gemäss Direktzahlungsverordnung (DZV).

10.Auf der Pakungsetikette ist die Empfehlung aufzuführen, dass vorzugsweise ein Handspritzgerät

verwendet werden soll.

Gefahrenkennzeichnungen:

Es gilt die Einstufung und Kennzeichnung der ausländischen Originaletikette.

Zusätzliche Schweizerische Gefahrenkennzeichnungen:

SP 1 Mittel und/oder dessen Behälter nicht in Gewässer gelangen lassen.

Im Zweifelsfall gelten einzig die Originaldokumente der Zulassung. Die Erwähnung eines Produktes,

Wirkstoffes oder einer Firma stellt keine Empfehlung dar und bedeutet nicht, dass sich das Produkt im

Verkauf befindet.

22-9-2018

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Risk assessment of new sequencing information for genetically modified soybean BPS‐CV127‐9

Published on: Fri, 21 Sep 2018 00:00:00 +0200 The GMO Panel has previously assessed genetically modified (GM) soybean BPS‐CV127‐9. This soybean was found to be as safe and nutritious as its conventional counterpart and commercial soybean varieties with respect to potential effects on human and animal health and the environment in the context of its intended uses. On 16 February 2018, European Commission requested EFSA to analyse new nucleic acid sequencing data and updated bioinformatics data for GM soy...

Europe - EFSA - European Food Safety Authority Publications

14-9-2018

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Development of an automated multienzymatic biosensor for risk assessment of pesticide contamination in water and food

Published on: Mon, 27 Aug 2018 00:00:00 +0200 The goal of this research is to better address the problems related to the widespread presence of pesticides in the environment. Despite the unquestionable utility of the pesticides against various pests in the agricultural field, most pesticides and the corresponding pesticide residues are toxic to the environment and hazardous to human health. The recent literature on organophosphate compounds emphasises a clear correlation between their use and the occurr...

Europe - EFSA - European Food Safety Authority Publications

21-6-2018

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

NOW Health Group, Inc. (NOW), of Bloomingdale, Illinois, is recalling its NOW Real Food® Zesty Sprouting Mix – Product Code 7271, Lot #3031259 and Lot #3038165 – because its primary ingredient, Crimson Clover Seeds, has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may b...

FDA - U.S. Food and Drug Administration

5-6-2018

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers by aligning USDA program with FDA’s Produce Safety Rule requirements.

FDA - U.S. Food and Drug Administration

29-5-2018

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion located in Asheville, NC is voluntarily recalling two of their Kratom products: Pious Lion Pure Premium Potent Limited Release Pink Bali, 1 oz and Pious Lion Pure Premium Potent White Maeng DA, Bright Uplifting Energy, 4 oz due to the presence of Salmonella . Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhe...

FDA - U.S. Food and Drug Administration

23-5-2018

Golden International Corporation  Issues Public Safety Warning For Stolen Tilapia Because  of Possible Health Risk

Golden International Corporation Issues Public Safety Warning For Stolen Tilapia Because of Possible Health Risk

Golden International Corporation of Renton, WA is issuing a public safety notice for 405 cartons of stolen frozen tilapia, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection wi...

FDA - U.S. Food and Drug Administration

21-5-2018

Ziyad Brothers Importing Recalls Tahini Because of Possible Health Risk

Ziyad Brothers Importing Recalls Tahini Because of Possible Health Risk

Ziyad Brothers Importing is voluntarily recalling certain lot codes of Ziyad Brand Tahini because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting, and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into ...

FDA - U.S. Food and Drug Administration

18-5-2018

MindFrame Capture LP Revascularization Device by Medtronic: Class I Recall - Due to Wire Material That May Break or Separate During Use

MindFrame Capture LP Revascularization Device by Medtronic: Class I Recall - Due to Wire Material That May Break or Separate During Use

There is a risk of the delivery wire breaking or separating during use. The clot retriever could be left inside the patient's bloodstream, and this or the attempts made to retrieve the device, can lead to further complications including bleeding, additional blockage of blood vessels, more severe stroke symptoms, or death.

FDA - U.S. Food and Drug Administration

19-4-2018

Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Viable Solutions of Nampa, ID has initiated a recall of certain Kratom-containing powder products, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result...

FDA - U.S. Food and Drug Administration

19-4-2018

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NGB Corp. of West Jordan, Utah is voluntarily recalling NxtGen Botanicals Maeng Da Kratom labeled bottles of encapsulated product because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infec...

FDA - U.S. Food and Drug Administration

14-9-2018

Hepar-SL® 640 mg

Rote - Liste

12-9-2018

 Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

Risk management plan information day, European Medicines Agency, London, UK, From: 25-Oct-2018, To: 25-Oct-2018

This information day will update participants on the Agency’s medicine risk management activities and provide advice to marketing authorisation holders and applicants on drafting a risk management plan (RMP) in view of the full implementation of the second revision of the RMP template after the transitional period has elapsed. It will also provide an opportunity for an exchange of experiences with this template between regulators and industry. A dedicated session will discuss the streamlining of safety s...

Europe - EMA - European Medicines Agency

13-8-2018

Today is Day 1 of the Pediatric Medical Device Development Public Meeting. Today we will discuss the programs, policies, and procedures at the #FDA intended to streamline evidence generation.  https://go.usa.gov/xU6rg 
#devices4kids #Pediatricspic.twitter

Today is Day 1 of the Pediatric Medical Device Development Public Meeting. Today we will discuss the programs, policies, and procedures at the #FDA intended to streamline evidence generation. https://go.usa.gov/xU6rg  #devices4kids #Pediatricspic.twitter

Today is Day 1 of the Pediatric Medical Device Development Public Meeting. Today we will discuss the programs, policies, and procedures at the #FDA intended to streamline evidence generation. https://go.usa.gov/xU6rg  #devices4kids #Pediatrics pic.twitter.com/3tXTgwPJPo

FDA - U.S. Food and Drug Administration

6-8-2018

Scientific guideline:  ICH M9 on biopharmaceutics classification system based biowaivers - Step 2b - First version, draft: consultation open

Scientific guideline: ICH M9 on biopharmaceutics classification system based biowaivers - Step 2b - First version, draft: consultation open

This new multidisciplinary guideline is proposed to address biopharmaceutics classification system (BCS)-based biowaivers. BCS-based biowaivers may be applicable to BCS Class I and III drugs, however BCS-based biowaivers for these two classes are not recognized worldwide. This means that pharmaceutical companies have to follow different approaches in the different regions. This guideline will provide recommendations to support the biopharmaceutics classification of medicinal products and will provide rec...

Europe - EMA - European Medicines Agency

22-7-2018

We’re exploring ways to use umbrella regulation or seek authority to address new risks faster. We're pursuing ways to spur innovation in safer devices; creating a Breakthrough Devices-like path  https://bit.ly/2O43EqH  and providing streamlined paths for

We’re exploring ways to use umbrella regulation or seek authority to address new risks faster. We're pursuing ways to spur innovation in safer devices; creating a Breakthrough Devices-like path https://bit.ly/2O43EqH  and providing streamlined paths for

We’re exploring ways to use umbrella regulation or seek authority to address new risks faster. We're pursuing ways to spur innovation in safer devices; creating a Breakthrough Devices-like path https://bit.ly/2O43EqH  and providing streamlined paths for comparative safety claims pic.twitter.com/30wLydOAec

FDA - U.S. Food and Drug Administration

18-7-2018

Knowing what software is included in a device means users and manufacturers can better assess and remediate potential cybersecurity threats that may emerge. #FDA looks forward to participating in the SBOM workstream and engaging broader perspective from t

Knowing what software is included in a device means users and manufacturers can better assess and remediate potential cybersecurity threats that may emerge. #FDA looks forward to participating in the SBOM workstream and engaging broader perspective from t

Knowing what software is included in a device means users and manufacturers can better assess and remediate potential cybersecurity threats that may emerge. #FDA looks forward to participating in the SBOM workstream and engaging broader perspective from the community.

FDA - U.S. Food and Drug Administration

18-7-2018

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a me

HSCC announced today a new workstream, conducted under the Task Group, that will discuss and seek input on a software bill of materials (SBOM) for medical devices. SBOMs can ensure that users have better understanding of what software elements are in a medical device.

FDA - U.S. Food and Drug Administration

4-6-2018

Automation of validation of eCTD and NeeS sequences

Automation of validation of eCTD and NeeS sequences

The TGA is currently undertaking work to streamline and automate our electronic dossier receipt system

Therapeutic Goods Administration - Australia

29-5-2018

EU/3/18/2016 (Abeona Therapeutics Europe SL)

EU/3/18/2016 (Abeona Therapeutics Europe SL)

EU/3/18/2016 (Active substance: Adeno-associated viral vector serotype 9 containing the human CLN1 gene) - Orphan designation - Commission Decision (2018)3383 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/013/18

Europe -DG Health and Food Safety